World Neuron Congress November 26-27, 2018 Helsinki, Finland

rTMS, a non-invasive technique for stimulation of neuronal cells, is one of the most promising tools for brain stimulation

and modulation and reversibly affect brain cortical activity and plasticity. Although rTMS has been used to treat a variety of

neuropsychiatric disorders, several lines of evidence suggest that rTMS has a potential efficacy to reduce cue-induced craving

in drug addiction. In this study, we employed real and sham rTMS of the Orbitofrontal cortex (OFC) and the left dorsolateral

prefrontal cortex (DLPFC) to compare and test if it could reduce cue-induced craving for methamphetamine (MA) after

the end of intervention and six month follow up. Thirty eligible MA-addicted patients were recruited to receive 10 sessions

of 20min sham or 10Hz rTMS to the left OFC and DLPFC. Subjects rated their craving at baseline, after exposed to MAassociated

cues and after rTMS sessions. They were followed after six months for the rate of relapse and adherence. Relative

decrease in severity of depression was greater in OFC group, however Kruskal-Walis test showed non-significant differences

among groups (p=0.097). Also, relative changes in psychopathology severity according to the Brief Psychiatric Rating Scale,

and relative changes in craving were not statistically different among groups (p=0.350 and p=0.905, respectively) This study

failed to show any efficacy of dorsolateral or orbitofrontal rTMS in comparison with sham rTMS in reducing psychopathology

or craving of the methamphetamine dependent patients.

Nataliia O Melnyk - the Professor of the Histology and Embryology Department of National O.O.Bogomolets Medical University, the Main Scientist in the Institute

of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine, Kyiv. Graduated from Kyiv National Taras Shevchenko University in

1993, after an assignment she worked as an engineer in the Institute of Molecular Biology and Genetics. During 2008- 2011, she worked as Deputy Head of the

Department of Education and Methodology of the National O.O. Bogomolets Medical University. She has more than 340 scientific and methodological works, 5

patents of scientific research. Nataliia Melnyk was edited base textbook of Histology, Cytology and Embryology for students of medical universities in Ukraine.

In experimental work was investigating morphological changers of neurons in organs of central nervous system (CNS) in

different experimental models of demyelination and remyelination. After induction of demyelination - EAE (experimental

allergic encephalomyelitis) - in rats, was investigate of changers of neurons in cortex of cerebrum, cerebellum and spinal

cord on 21 days and 39 days. We observed the percentage of neurons with unmodified, moderate and severe structural

changes after staining of histological sections of the brain and spinal cord by toluidine blue and cresyl violet. We studied of

demyelination process of nervous fibers in organs of CNS by the methods of electron microscopy and morphometry. We

observed of remyelination process - the percentage of normal neurons in the brain and spinal cord was increased, the amounts

of neurons with severe and destructive changes were reduce after influence of Rebif® (interferon beta-1a) by 1 and 2 weeks, and

myelinated nerve fibers was regenerate. After induction of demyelination - cuprizone model - in the 129/Sv mice, at 3-5 and 16-

17 months of age we observed changers in structure of neurons and nerve fibers. Cuprizone was provide daily for 3 weeks, in

result, was form demyelination process in CNS. RhLIF was inject after 7-days cuprizone diet, one administration daily, 50 μg/

kg, the hormone of melatonin was provide daily. In the cuprizone-treated mice of both age groups, the percentage of neurons

with severe changes in the brain and spinal cord was increased and after rhLIF and melatonin, the amounts of neurons with

destructive changes were reduce, was less pronounce in aged mice. RhLIF and melatonin may be a perspective neuroprotective drugs.

Sarwar Jamil Siddiqui is graduated from Dow Medical College, Karachi, Pakistan in 1985. He trained in General Medicine and Neurology at St Margaret’s Hospital,

Epping, Princess Alexandra Hospital, Harlow and St Bartholomew’s Hospital, London, England. He is also a member of American Academy of Neurology. He is

Dean, Faculty of Neurology at the College of Physicians & Surgeons of Pakistan and is responsible for Neurology Postgraduate Training in the whole country which

includes 24 training centers. This is his 4th consecutive tenure as Dean. He is also Chairman of the Editorial Board of the Journal of Pakistan Medical Association

His interests include General Neurology, Movement Disorder and Parkinson’s disease and Neurology Education and Training.

Pakistan is a developing country in Southeast Asia with a population of 210 million. There are about 210 practicing neurologist

in the country at present. Neurology as a specialty in Pakistan started in 1963. To start off with there were 5 neurologists,

all British trained from 1963-1969. Then more neurologists returned from abroad, especially after 1992, mainly trained in the

UK and USA. Intrinsic neurology training program started in 1990 by the College of Physicians & Surgeons, Pakistan. The first

Pakistani trained neurologist qualified in 1995. Since then the College has trained 202 neurologists to date who qualified FCPS

(Neurology) Examination after a 5-year structured training program. About 45 specialists trained in Pakistan are working

in the Middle East, UK and Canada. At present there are 21 approved neurology training centers and 24 approved training

supervisors in the country where over 120 postgraduates are undergoing training. The training includes 2 years in Internal

Medicine followed by a 3-year specialty training in Neurology. In addition to above, universities offer postgraduates programs

in Neurology namely, Diploma in Clinical Neurology (one year program) and MD (Neurology) which is a 3-year training

program in Clinical Neurology. There is a sizeable research contribution in the field of Neurology from Pakistan. The number

of research papers published in peer-reviewed journals from Pakistan was over 140 in 2017 alone.

Shlomi Hanassy is the owner and establisher of Hanassy R&D Ltd. IL. Shlomi is an algorithm developer and neurobiologist specialized in motor control and vision processing. He is also an inventor and experienced developer of several innovations in those fields. In 2011-2012 he worked as algorithm developer at Wellsens tech (http://www.wellsense-tech.com/), developing algorithms for pressure mat while serving as a consultant for the EU “Stiff-flop” project (http://www.stiff-flop.eu/). During 2007-2010 he was a Phd student and algorithm developer of visual substitution devises at Amir Amedi’s lab for higher brain functions while serving as a coworker in Benny Hochner’s lab for motor control and at the EU “Octopus project”(http://www.octopusproject.eu/). Since 2007 Shlomi is holding an M.sc in medical neurobiology from the Hebrew University (Hadassah Ein Carem medical school) and a B.A in computer science and administration from the Open University of Israel (since 2003).

Octopuses where always a fascinating animals with their spectacular line of

unique features. Here will review many of those features focusing on the

arm motor control. Similar to tongue and the elephant trunk, the octopus arm

is a muscle hydrostat, hyper-redundant, structure. The computational process

involved in the generation of a movement in such structure is a highlight

for motor control engineers. During that process, a reduction of the motor

control problem complexity is obtained by reducing degrees of freedom,

using stereotypical motor primitives, which are simply modulated instead of

calculated, to achieve the required movement. That principle inspired many

robotic engineers to achieve new kind of control: embedded intelligence. Here

we will present some results of such bio-robotic engineering and novel applications.

Diana G Rotaru is currently a PhD student in the Neuroimaging Department at Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and

Neuroscience, King’s College London. She completed her BSc at the Faculty of Medical Engineering, University Politehnica of Bucharest with a thesis focused

on EEG seizure detection using artificial intelligence. Later, her research interests turned to neuroimaging and she graduated with an MSc in Neuroimaging. She

decided to continue her dissertation project and she is working now on Magnetic Resonance Spectroscopy method development aiming to provide the tools

necessary for precise and direct measurement of low concentration neuro-metabolites on clinical and preclinical moderate-to-high-field MRI scanners.

As the non-invasive evaluation of brain metabolism is considered an important factor in the understanding of neurological

and psychiatric disorders (Alzheimer’s Disease, Parkinson’s Disease, epilepsy, schizophrenia, autism, ADHD, psychosis,

bipolar disorder, major depressive disorder, etc.) more interest has been given to Magnetic Resonance Spectroscopy (MRS).

Based on recent work on spectral editing schemes, discrimination and quantification of otherwise unresolvable neurometabolites

like GABA (Gamma-Amino butyric Acid, the main inhibitory neurotransmitter) and GSH (glutathione, an

antioxidant found throughout the brain) becomes possible. The purpose of our study was to test if HERMES (Hadamard

Encoding and Reconstruction of MEGA-Edited Spectroscopy) could be used to discriminate between GABA and GSH. A

comparison with standard methods (MEGA-PRESS - MEshcher-GArwood Point REsolved Spectroscopy) and test-retest

reproducibility were also considered. A special proton MRS (1H-MRS) acquisition protocol was implemented on our 3T

MR750 General Electric scanner. The HERMES pulse sequence was then tested in phantom and in vivo experiments, for the

latter, a voxel in the dorso-medial prefrontal cortex (DMPFC) being prescribed. For the measurement of the edited signal,

two software packages were used: LC Model, along with FID-A pre- processing and Gannet, which currently can be used

without any additional pre-processing steps. The acquisition results showed that spectral editing was successfully performed,

with GABA and GSH being edited correctly considering the spectral appearance and the concentration values. Regarding

the analysis methods, LC Model and Gannet were both suitable for HERMES data sets. The test-retest reliability was assessed

based on the concentration values we obtained and suggests there was a strong consistency between test-retest results for

the same method of analysis. The advantages of the HERMES pulse sequence over conventional MR protocols include time

efficiency, high-quality results and cost- effectiveness. As such, with HERMES we were able to obtain GABA and GSH spectra

simultaneously in one scanning session no longer than 12 minutes, while the time required when using MEGAPRESS for the

both GABA&GSH is double, one session of 12 minutes being necessary for each metabolite. The long-term benefits of using

HERMES include the development of a reliable tool for neuroimaging research along with improved healthcare solutions

(patient stratification, early disease detection, accurate diagnosis, treatment tracking and drug therapy evaluation).

Rahul Srinivasan is pre final resident in Neurosurgery department at Medical Trust Hospital Kochi, Kerala. He is also member of Cochin neurological society and

neurological society of India. He has co authored various articles in field of neurotrauma. Last article related to ICP monitoring was published in Acta Neurochirugica

in 2018. During his post graduation he has assisted multiple cranial, spinal surgeries and endovascular procedure. He has won best poster award at PULSUS

Conference at Singapore conducted in September 2018. His current research also continues in field of Neuro trauma.

Perimedullary AV fistula is not common disease. Here we present a case of 11-year-old boy who presented with sudden

onset severe headache and neck pain for 1 day. He was having similar episodes in the past and treated as migraine. Imaging

revealed SAH in posterior fossa and cervical subarachnoid space. There were multiple flow voids around lower cervical cord

suggesting vascular malformation. Patient underwent spinal and brain DSA, which revealed diagnosis of single hole single

feeder cervical perimedullary AVF with feeding artery aneurysm as a cause of SAH. He was treated by endovascular means

with 5 month imaging follow up.